GHK-Cu

GHK-Cu Injection Dosing: Where the Real Number Comes From

There is no standard protocol. There is your label, and there is your prescriber.

5 min read·Sources: FDA prescribing information, peer-reviewed trials and NIH literature·Updated August 2026·Educational content, not medical advice
The short answer

GHK-Cu has no FDA-approved dosing, because it is not an FDA-approved drug. When a clinician prescribes a compounded preparation, the dose, site, and frequency come from your dispensed label - not from a community protocol, since concentrations differ between pharmacies and preparations.

See your price Takes about 10 minutes · a clinician can decline · full refund if not prescribed
A clinician's hands holding a blank clipboard across a desk

Why community numbers fail

Injection protocols shared online quote milligram amounts without stating concentration, and concentrations vary widely between compounded preparations. The same volume can deliver very different amounts. A number without its concentration is not a dose.

Where your real number lives

Two places that should agree: the concentration printed on the vial, and the draw and frequency written in your dispensed instructions. If they conflict, call the pharmacy before injecting – not after.

Site and technique

Your instructions specify the site; rotation between sites is standard practice for any repeated subcutaneous injection. Sterile technique, a fresh needle every time, and an FDA-cleared sharps container are not optional extras.

Finasteride is FDA-approved as a brand product for androgenetic alopecia in men.

FDA prescribing information, finasteride ↗

The research-powder trap

Unregulated 'research grade' peptide powder sold for self-mixing carries genuine purity and sterility risk, and reconstitution errors are dosing errors. If a clinician has not prescribed it and a licensed pharmacy has not prepared it, the dose question is the smaller of your problems. See the 30-second film answers for this medication.

How GHK-Cu is described to work

GHK-Cu is a tripeptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. The peptide occurs naturally in human plasma and declines with age. In laboratory and animal work it has been associated with signalling related to collagen synthesis, wound repair, and antioxidant activity, and the copper ion is itself a cofactor for lysyl oxidase, an enzyme involved in cross-linking collagen. That is a mechanistically coherent story, and it is largely preclinical. Human clinical evidence for cosmetic or therapeutic outcomes from compounded GHK-Cu is limited. Compounded preparations are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. How to use GHK-Cu covers the practical handling; whether it is appropriate for you is a clinician’s decision.

Routes, handling, and what the instructions govern

GHK-Cu is prepared topically and, in some compounded formulations, for injection, and the handling requirements differ accordingly. Copper peptide preparations are generally kept cool and away from light, because both temperature and light drive degradation, and the dispensing pharmacy sets the storage and beyond-use instructions for your specific preparation. Those instructions govern over anything written on a website. Do not use a preparation whose colour or clarity has changed. GHK-Cu dosing covers what is described in practice, all of it set by the prescribing clinician rather than by a published standard.

What is not established, stated plainly

The mechanistic case for GHK-Cu rests largely on laboratory and animal work. Human clinical trial evidence for cosmetic or wound-healing outcomes from compounded preparations is limited, and compounded preparations are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing. Copper is also a mineral with a genuine upper limit, so anyone with Wilson’s disease or a copper metabolism disorder should raise that specifically. A clinician weighs the uncertainty against your history and may decline.

What to ask before starting a copper peptide

Three questions separate a considered decision from a purchase. First, what is the evidence base for the specific outcome being described, and for compounded GHK-Cu the honest answer is that most of it is preclinical. Second, which licensed pharmacy compounds and dispenses this preparation, and is that pharmacy named and verifiable. Third, what would the clinician consider a reason to stop. Compounded preparations are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. Red flags when buying online covers how to evaluate a seller, and a licensed clinician decides whether treatment is appropriate for you at all.

Tired of reading and still not knowing?

A clinician reviews your intake and gives you a real answer, not another article.

See if you qualifyTakes about 10 minutes · a clinician can decline · full refund if not prescribed

Frequently asked questions

Is there a standard daily GHK-Cu dose?

No. It is not FDA-approved, so there is no approved dose – only what your clinician prescribes and your pharmacy dispenses.

Can I use a topical protocol as a guide for injection?

No – routes are not interchangeable and absorption differs completely. Never convert between them yourself.

What if my new vial looks different?

Re-read the label and instructions with every fill; concentration can change between preparations.

What is GHK-Cu?

A tripeptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. It occurs naturally in human plasma and declines with age.

Does GHK-Cu work?

Laboratory and animal work associates it with collagen synthesis and wound-repair signalling. Human clinical evidence for compounded preparations is limited, and they are not FDA-approved.

How do you use GHK-Cu?

Follow the route and instructions supplied with your preparation. A licensed clinician determines whether it is appropriate for you.

Get your protocol from a prescriber

A licensed clinician reviews your history and decides what is appropriate. Rx only, refunded in full if you are not prescribed.

Takes about 10 minutes · a clinician can decline · full refund if not prescribed

Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.

Sources

Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.

  1. FDAFDA. Compounding and the FDA: questions and answers
  2. Peer-reviewedPickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci 2018;19(7):1987
  3. Research databaseSearch the literature: GHK-Cu peptide research

Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.

More on GHK-Cu

Same medication, different question.

See your price